Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial

MT Smith - Pain, 2022 - journals.lww.com
Globally, the prevalence of chronic pain is high at 10% to 50% of the adult population. 18,
23, 40, 57, 63, 64 Chronic pain not only impairs the quality of life of patients and their …

Contemporary and emergent pharmacological therapies for chronic pain: nonopioid analgesia

JM Cox, M Pappagallo - Expert Review of Neurotherapeutics, 2001 - Taylor & Francis
The American Pain Society estimates that 50 million Americans are partially or totally
disabled by pain. This striking statistic is certain to increase as our population continues to …

Pain—novel targets and new technologies

S Hua, PJ Cabot - Frontiers in Pharmacology, 2014 - frontiersin.org
Pain is a major health problem that significantly affects the quality of life of patients. It has a
significant impact on both the sufferers and the broader community, imparting high health …

Re-energizing the development of pain therapeutics in light of the opioid epidemic

P Skolnick, ND Volkow - Neuron, 2016 - cell.com
Limited options for treating moderate-severe pain led to an overreliance on opioids and the
current opioid epidemic. Addressing the factors contributing to a dearth of effective …

Development of new analgesics: an answer to opioid epidemic

TL Yaksh, MA Hunt, GG Dos Santos - Trends in Pharmacological Sciences, 2018 - cell.com
Management of pain is a fundamental imperative in medicine. Current analgesics suffer from
limitations related to efficacy and adverse events of which abuse potential has assumed an …

Breaking barriers to novel analgesic drug development

AS Yekkirala, DP Roberson, BP Bean… - Nature reviews Drug …, 2017 - nature.com
Acute and chronic pain complaints, although common, are generally poorly served by
existing therapies. This unmet clinical need reflects a failure to develop novel classes of …

[PDF][PDF] Receptor and molecular targets for the development of novel opioid and non-opioid analgesic therapies

R Chen, M Coppes, RD Urman - Pain Physician, 2021 - painphysicianjournal.com
Background: Although conventional pain relief therapeutics have centered around μ-opioid
agonists, these drugs are limited by adverse side effects, including respiratory depression …

Non-pharmacological treatment of pain: grand challenge and future opportunities

MC Bushnell, E Frangos, N Madian - Frontiers in Pain Research, 2021 - frontiersin.org
The “Non-pharmacological treatment of pain” section of the Frontiers in Pain Research was
initiated to reflect the growing appreciation for the role that complementary interventions play …

Opportunities and challenges for nonaddictive interventions in chronic pain

V Malafoglia, M Tenti, S Ilari, E Balzani, A Fanelli… - Current opinion in …, 2021 - Elsevier
The worlds of chronic pain and addiction continue to intersect too often in many ways.
Chronic pain significantly impairs and disrupts the quality of life of millions of people …

The race to control pain: more participants, more targets

BA Chizh, AH Dickenson, S Wnendt - Trends in pharmacological sciences, 1999 - cell.com
The surge of pain-related publications over the past few years and substantial advances in
the understanding of pain and analgesia have come about not least because of an ever …